The Consulate General of Finland introduces Jon Jurva, Finnish Honorary Consul in Chicago, highlighting his contributions to supporting diplomatic and cultural ties between Finland and the US.
Partner David Greenberg was quoted on a series of patient lawsuits challenging the alleged use of artificial intelligence (AI) and algorithms by health insurers, commenting on the potential hazards of insurers using the technology.
Partner David Dubrow was quoted on the use of artificial intelligence in fraud in response to the US Securities and Exchange Commission’s (SEC) complaint against three individuals who allegedly use fake documents to defraud investors in municipal bonds.
Health Care Practice Leader Douglas A. Grimm was quoted by Relias Media, urging hospitals and health care providers to prepare for potential Immigration and Customs Enforcement raids at their locations, following the Trump administration’s revocation of policies that previously made hospitals off-limits for immigration enforcement.
Partner J. Michael Showalter was quoted on President Donald Trump’s new policy invoking Rule65(c) of the Federal Rules of Civil Procedure as a litigation-deterrence strategy.
Partner Alexander Birkhold was quoted in a recent discussion on the effectiveness of “click-through training,” referring to trainings using click-through screens and multiple-choice tests, in corporate compliance training.
Proposed settlement requires Leader and its Canadian parent company, AutoCanada, to turn over $20 million, include full offering price in ads, and get consent for all charges.
Health Care Practice Leader Douglas A. Grimm was quoted by Law360, urging hospital leaders and lawyers across the country to start implementing new strategies after the Trump Administration pulled back a Biden Administration 2021 directive to avoid immigration enforcement at certain locations, including hospitals.
In his published article, “The Corporate Transparency Act Whipsaw Continues,” Partner Evgeny Magidenko provides an in-depth analysis of the current legal landscape surrounding the Corporate Transparency Act (CTA) following a series of judicial decisions.
On December 12, the US Food and Drug Administration (FDA) announced the availability of updated final guidance on cosmetic facility registration and cosmetic product listing. If you are experiencing déjà vu, you are not alone — the FDA announced the issuance of the same final guidance almost exactly one year ago, on December 18, 2023.
Health Care Practice Leader Douglas A. Grimm was quoted by Law360 discussing the lack of regulation surrounding the use of AI within health care.
Health Care Partner Jill A. Steinberg was quoted by Bloomberg Law on the expected difficulties in finding associational standing following the US Supreme Court’s dismissal of a challenge regarding standing against the US Food and Drug Administration.
In an interview with Harvard Law School, AFS Chairman Anthony V. Lupo talked about his role in helping shape the rise of fashion and retail law, AFS’s unique culture, and new legal industry trends to anticipate.
Presently, there is no overarching federal law or regulatory scheme specific to the unique challenges of AI. This places AI regulation on track to follow the same path as privacy/data collection—with the states, the courts, the industry itself, and other jurisdictions trying to fill the void.
The nation’s car dealerships experienced total losses of more than $1 billion as the result of a nationwide hacking and ransomware attack on their software and systems last month.
Customs Practice Leader and AFS Forced Labor Task Force Leader Angela M. Santos was quoted regarding the recent US Department of Homeland Security Uyghur Forced Labor Prevention Strategy Update.
Hyundai said it does not ‘condone any intentional falsification of sales reporting data and [has] launched an immediate investigation.’
A group of Hyundai Motor dealers has sued the South Korean automobile giant in Chicago federal court for allegedly inflating sales numbers for electric vehicles.
Partner Emily Cowley Leongini was quoted in a recent Axios article on the Food and Drug Administration’s implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which established a July 1 deadline for companies to register their products and facilities with FDA.
Partner J. Michael Showalter was quoted on the US Supreme Court ruling that overturned the so-called Chevron deference, a 40-year-old doctrine giving federal agencies deference in interpreting laws.
Health Care Practice Leader Douglas A. Grimm was quoted on pharmaceutical manufacturers easing restrictions on 340B drug discounts as more states attempt to make the program’s benefits accessible.
Health Care Practice Leader Douglas A. Grimm was quoted on the Federal Trade Commission’s (FTC) rejected bid to block a proposed merger between two North Carolina hospitals.
Sarah A. W. Fitts, Steven Sung Soo Yoon, Justin A. Goldberg, Jonathan P. Bagg, Peter T. Butler, Christopher K.S. Wong, Patrick Lai, Victoria F. Wiener
Aymium, a leading producer of renewable biocarbon products, announced that it closed $210 million of financing to construct a biocarbon production facility in Williams, California.
Trade Secrets, Noncompetes & Employee Mobility Practice Co-Leader Linda M. Jackson was quoted on the trade secrets risks facing employers from large-scale employee movement and with the impending Federal Trade Commission rule banning most noncompetes.
Partner David Loring was quoted by Law360 discussing the impact of the US Environmental Protection Agency’s (EPA) final rule limiting greenhouse gas emissions from power plants.